An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infection
Keywords: KSHV, Kaposi’s sarcoma-associated herpesvirus; KS, Kaposi’s sarcoma; MCD, multicentric Castleman’s disease; PEL, primary effusion lymphoma; HAART, highly active antiretroviral therapy; mAb, monoclonal antibody; FBS, fetal bovine serum; scFv, single chain